Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable Endostatin
- 1 July 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (1) , 313-320
- https://doi.org/10.1016/s0002-9440(10)61697-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antiangiogenic Gene Therapy for Cancer via Systemic Administration of Adenoviral Vectors Expressing Secretable EndostatinHuman Gene Therapy, 2000
- Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosisArthritis & Rheumatism, 2000
- Antiangiogenic Activity of the Cleaved Conformation of the Serpin AntithrombinScience, 1999
- Dramatic Inhibition of Retinal and Choroidal Neovascularization by Oral Administration of a Kinase InhibitorThe American Journal of Pathology, 1999
- Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine ModelThe American Journal of Pathology, 1998
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Inhibition of angiogenesis by tissue inhibitor of metalloproteinaseJournal of Cellular Physiology, 1994
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor geneCell, 1989
- Astrocytes induce blood–brain barrier properties in endothelial cellsNature, 1987